Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Glaxosmithkline (GSK) Regulatory News

Date Source Headline
7th Jun 2022 12:00 pm EQS Hardman & Co Life Sciences Research: Long-term pharmaceutical industry cost and EBIT analysis
6th Jun 2022 7:00 am RNS US FDA approval of Priorix
1st Jun 2022 4:55 pm RNS Total Voting Rights
1st Jun 2022 1:00 pm RNS Demerger update: Publication of Documents
1st Jun 2022 7:00 am RNS Demerger update: Submission of Documents to FCA
31st May 2022 7:00 am RNS GSK to acquire Affinivax, Inc.
30th May 2022 10:00 am RNS Further appointments to Designate Haleon Board
27th May 2022 7:00 am RNS GSK Cervarix two-dose schedule approved by NMPA
25th May 2022 3:41 pm PRN Director/PDMR Shareholding
23rd May 2022 3:21 pm RNS Director/PDMR Shareholding
19th May 2022 10:02 am RNS Iain Mackay - External Appointment
16th May 2022 2:00 pm RNS Change of name to GSK plc
13th May 2022 5:13 pm RNS Director/PDMR Shareholding
12th May 2022 8:58 am RNS Director/PDMR Shareholding
11th May 2022 5:17 pm RNS Block listing Interim Review
9th May 2022 2:53 pm RNS Director/PDMR Shareholding
4th May 2022 5:49 pm RNS Result of AGM
4th May 2022 10:00 am RNS Directorate Change
3rd May 2022 4:52 pm RNS Total Voting Rights
27th Apr 2022 7:00 am RNS 1st Quarter Results
26th Apr 2022 9:32 am RNS Director/PDMR Shareholding
19th Apr 2022 7:00 am RNS Daprodustat application accepted for review by FDA
14th Apr 2022 2:23 pm RNS Director/PDMR Shareholding
14th Apr 2022 2:15 pm RNS Director/PDMR Shareholding
14th Apr 2022 1:29 pm RNS Director/PDMR Shareholding
13th Apr 2022 5:11 pm RNS Director/PDMR Shareholding
13th Apr 2022 9:32 am RNS Director/PDMR Shareholding
13th Apr 2022 7:00 am RNS GSK agrees to acquire Sierra Oncology for $1.9bn
12th Apr 2022 5:10 pm RNS Director/PDMR Shareholding
12th Apr 2022 4:23 pm RNS Director/PDMR Shareholding
12th Apr 2022 4:00 pm RNS Director/PDMR Shareholding
12th Apr 2022 3:48 pm RNS Director/PDMR Shareholding
1st Apr 2022 4:03 pm RNS Total Voting Rights
1st Apr 2022 11:20 am RNS GSK - segment and product sales reporting changes
28th Mar 2022 1:00 pm RNS Publication of 2022 AGM Notice
24th Mar 2022 3:22 pm RNS Director/PDMR Shareholding
24th Mar 2022 2:00 pm RNS FDA update: Cabenuva oral lead-in now optional
23rd Mar 2022 5:03 pm RNS Director/PDMR Shareholding
23rd Mar 2022 7:00 am RNS Issuance of Notes
16th Mar 2022 2:40 pm RNS Director/PDMR Shareholding
FTSE 100 Latest
Value8,632.33
Change89.77